- Home
- ENS vs RNA Comparison
ENS vs RNA Comparison
Compare ENS & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENS
- RNA
- Stock Information
- Founded
- ENS 1991
- RNA 2012
- Country
- ENS United States
- RNA United States
- Employees
- ENS N/A
- RNA N/A
- Industry
- ENS Industrial Machinery/Components
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- ENS Technology
- RNA Health Care
- Exchange
- ENS Nasdaq
- RNA Nasdaq
- Market Cap
- ENS 3.4B
- RNA 4.0B
- IPO Year
- ENS N/A
- RNA 2020
- Fundamental
- Price
- ENS $98.35
- RNA $46.47
- Analyst Decision
- ENS Strong Buy
- RNA Strong Buy
- Analyst Count
- ENS 2
- RNA 15
- Target Price
- ENS $117.50
- RNA $68.40
- AVG Volume (30 Days)
- ENS 362.3K
- RNA 3.7M
- Earning Date
- ENS 08-06-2025
- RNA 08-07-2025
- Dividend Yield
- ENS 0.98%
- RNA N/A
- EPS Growth
- ENS 32.64
- RNA N/A
- EPS
- ENS 8.77
- RNA N/A
- Revenue
- ENS $3,657,687,000.00
- RNA $10,729,000.00
- Revenue This Year
- ENS $2.47
- RNA N/A
- Revenue Next Year
- ENS $3.32
- RNA $196.18
- P/E Ratio
- ENS $11.22
- RNA N/A
- Revenue Growth
- ENS 3.73
- RNA 1.23
- 52 Week Low
- ENS $76.57
- RNA $21.51
- 52 Week High
- ENS $104.36
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- ENS 64.72
- RNA 73.24
- Support Level
- ENS $94.52
- RNA $45.06
- Resistance Level
- ENS $100.44
- RNA $47.24
- Average True Range (ATR)
- ENS 2.07
- RNA 2.66
- MACD
- ENS 0.62
- RNA 0.55
- Stochastic Oscillator
- ENS 82.11
- RNA 86.85
About ENS EnerSys
EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.